
What if we could predict age-induced health issues before they happen? Our new PROSPR program aims to identify biochemical and physiological markers, paving the way for faster, more targeted aging research. arpa-h.gov/news-and-event…
Andrew Brack
2.6K posts

@BrackLab
Scientist interested in preventing functional decline during aging. Program Manager at ARPA-H. Interests: Crypto, Everton FC and Boxing. Views are my own.

What if we could predict age-induced health issues before they happen? Our new PROSPR program aims to identify biochemical and physiological markers, paving the way for faster, more targeted aging research. arpa-h.gov/news-and-event…





Friedberg: New study shows enzyme reverses skin age from 70+ years to 31 Chamath: That’s a $2T market. Did Scientists Just Discover How to Reverse Skin Aging!? “CML is kind of the predominant molecule that gets formed in this extracellular matrix that's driving aging, and nothing breaks it down. So these scientists set out to try and create an enzyme, an enzyme is a protein that breaks something down, that can break down CML. And so these guys kind of went out and they took the target, which is CML, and tried to figure out, ‘Okay, how do we actually degrade CML, clear that extracellular matrix, and reverse aging?’ They started to test it on the proteins that we would find in our body, casein, collagen, retinal proteins, which are in your eye, hemoglobin, and they were able to get rid of 52 to 97% of the CML, just degrade it away. And then they found several sites where they were able to degrade over 90%. And then they took actual human skin from elderly patients that had donated their skin, and they put this enzyme onto that skin, and they were able to eliminate 55% of the CML on the skin, basically reverse the skin's age down to the age of a 31-year-old, this is from greater than 70-year-old patients, just by putting this enzyme on the skin. And so it's kind of a groundbreaking demonstration of combination of AlphaFold, what's called directed evolution, where you change the order of the DNA that changes the structure of the protein to test different proteins, do high throughput screening, and ultimately make a novel protein that doesn't exist in nature today that can do something pretty profound for human health.” Chamath: “It will be a trillion-dollar market. If you can create a cream…” Friedberg: “I mean, dude, if you could put this enzyme literally on your skin and have it absorb in…” Chamath: “Game over. That alone is $2 trillion.”


@MrBeast I'll take the billion and solve aging.




NIH is modernizing how it makes funding decisions. The new Unified Funding Strategy keeps peer review foundational while allowing NIH to consider the full picture, including scientific merit, innovation, public health needs, and emerging research opportunities. Learn more: bit.ly/4vUFLqj



Tomorrow, the @HouseCommerce Subcommittee on Health will examine how the @US_FDA can maintain America's leadership in biomedical innovation and strengthen U.S. drug development. Modernizing the regulatory framework is essential if we want to accelerate innovation, maintain our competitive edge in the biomedical sector, and ensure patients have access to the next generation of treatments. A4LI has submitted a letter for the hearing record urging Congress to consider our Multi-Disease Therapeutic Designation (MDTD) proposal: a regulatory pathway designed to better support therapies that target the underlying biology of aging and reduce the burden of multiple chronic diseases. 📄 Read our MDTD proposal here: a4li.org/wp-content/upl… We are thrilled to see Congress continuing this important conversation about the future of biomedical innovation, and we look forward to hearing expert perspectives on how the FDA can help foster this next generation of medical breakthroughs. ▶️ The full hearing can be livestreamed here: youtube.com/watch?v=sTL86n…






A prescription shouldn’t be a guessing game. ARPA-H’s IndiPHARM uses one blood sample + AI-powered analysis to predict exactly how patients metabolize drugs. New research proves why this matters for diabetes. Read the paper. 👇 …ubs.pericles-prod.literatumonline.com/doi/10.1111/do… @ColumbiaMSPH @GaryWMiller3 @MayoClinic @EmoryUniversity @BrownUniversity @jacksonlab








Standard disease frameworks are meeting their match as pioneers lean on functional metrics and pragmatic stepping stone indications. vist.ly/5aq23 #longevity #geroscience #fda #clinicaltrials #regulation @ARPA_H @xprize





